Interventions to Disrupt Coronavirus Disease Transmission at a University, Wisconsin, USA, August-October 2020.

COVID-19 COVID-19 testing SARS-CoV-2 United States University of Wisconsin–Madison Wisconsin coronavirus disease dormitory respiratory infections severe acute respiratory syndrome coronavirus 2 students university viruses whole-genome sequencing zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 30 9 2021
medline: 27 10 2021
entrez: 29 9 2021
Statut: ppublish

Résumé

University settings have demonstrated potential for coronavirus disease (COVID-19) outbreaks; they combine congregate living, substantial social activity, and a young population predisposed to mild illness. Using genomic and epidemiologic data, we describe a COVID-19 outbreak at the University of Wisconsin-Madison, Madison, Wisconsin, USA. During August-October 2020, a total of 3,485 students, including 856/6,162 students living in dormitories, tested positive. Case counts began rising during move-in week, August 25-31, 2020, then rose rapidly during September 1-11, 2020. The university initiated multiple prevention efforts, including quarantining 2 dormitories; a subsequent decline in cases was observed. Genomic surveillance of cases from Dane County, in which the university is located, did not find evidence of transmission from a large cluster of cases in the 2 quarantined dorms during the outbreak. Coordinated implementation of prevention measures can reduce COVID-19 spread in university settings and may limit spillover to the surrounding community.

Identifiants

pubmed: 34586058
doi: 10.3201/eid2711.211306
pmc: PMC8544969
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2776-2785

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM140935
Pays : United States

Références

MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1416-1418
pubmed: 33001871
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Trends Cogn Sci. 2020 Aug;24(8):585-587
pubmed: 32444200
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
JAMA Netw Open. 2020 Jul 1;3(7):e2016818
pubmed: 32735339
JAMA. 2020 Nov 3;324(17):1727-1728
pubmed: 32991681
Cell. 2020 May 28;181(5):990-996.e5
pubmed: 32386545
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):114-117
pubmed: 33507887
MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1419-1424
pubmed: 33006586
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):118-122
pubmed: 33507894
Nat Commun. 2020 Nov 3;11(1):5558
pubmed: 33144575
Genome Res. 2020 Dec;30(12):1781-1788
pubmed: 33093069
MMWR Morb Mortal Wkly Rep. 2021 Jan 08;70(1):20-23
pubmed: 33411698
Nat Commun. 2020 Nov 2;11(1):5518
pubmed: 33139704
BMJ. 2020 Sep 1;370:m3365
pubmed: 32873595
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Science. 2021 Feb 5;371(6529):
pubmed: 33303686
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
MMWR Morb Mortal Wkly Rep. 2021 Jan 08;70(1):14-19
pubmed: 33411699
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH